Cue Health PE Ratio 2020-2023 | HLTH

Current and historical p/e ratio for Cue Health (HLTH) from 2020 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Cue Health PE ratio as of April 23, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Cue Health PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-04-23 0.15 0.00
2023-12-31 0.16 $-2.44 0.00
2023-09-30 0.44 $-1.69 0.00
2023-06-30 0.37 $-1.83 0.00
2023-03-31 1.82 $-1.95 0.00
2022-12-31 2.07 $-1.31 0.00
2022-09-30 3.01 $-0.88 0.00
2022-06-30 3.20 $-0.30 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.024B $0.071B
Cue Health Inc. is a health technology company. It offers individuals, enterprises, government agencies and healthcare provides access to lab-quality diagnostic testing at home, at work or at the point-of-care, all in a device. Cue Health Inc. is headquartered in San Diego.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $39.354B 21.89
Inspire Medical Systems (INSP) United States $7.087B 0.00
IRhythm Technologies (IRTC) United States $3.621B 0.00
Axonics (AXNX) United States $3.390B 0.00
10x Genomics (TXG) United States $3.287B 0.00
Enovis (ENOV) United States $3.042B 23.11
Azenta (AZTA) United States $2.930B 238.82
Olink Holding AB (publ) (OLK) Sweden $2.760B 0.00
Hims & Hers Health (HIMS) United States $2.642B 0.00
Privia Health (PRVA) United States $2.231B 98.95
Schrodinger (SDGR) United States $1.794B 0.00
Omnicell (OMCL) United States $1.306B 31.94
Phreesia (PHR) United States $1.305B 0.00
Definitive Healthcare (DH) United States $0.856B 0.00
Standard BioTools (LAB) United States $0.743B 0.00
Fulgent Genetics (FLGT) United States $0.617B 0.00
Talkspace (TALK) United States $0.530B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.330B 0.00
Health Catalyst (HCAT) United States $0.328B 0.00
Clover Health Investments (CLOV) United States $0.312B 0.00
Pulmonx (LUNG) United States $0.289B 0.00
P3 Health Partners (PIII) United States $0.162B 0.00
MSP Recovery (LIFW) United States $0.158B 0.00
American Well (AMWL) United States $0.157B 0.00
Butterfly Network (BFLY) United States $0.154B 0.00
Augmedix (AUGX) United States $0.138B 0.00
Outset Medical (OM) United States $0.127B 0.00
TruBridge (TBRG) United States $0.119B 5.06
111 (YI) China $0.091B 0.00
SHL Telemedicine (SHLT) Israel $0.079B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) China $0.052B 0.00
EUDA Health Holdings (EUDA) Singapore $0.047B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.032B 0.00
Movano (MOVE) United States $0.027B 0.00
Bullfrog AI Holdings (BFRG) United States $0.023B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
Strata Skin Sciences (SSKN) United States $0.019B 0.00
Akili (AKLI) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Biotricity (BTCY) United States $0.014B 0.00
Centogene (CNTG) Germany $0.013B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Syra Health (SYRA) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Zhongchao (ZCMD) China $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00